On November 12, 2021, CMS officially and finally announced it was *canceling* the "MCIT" rule, which had been finalized in the closing weeks of the Trump administration in January.
The Medical Coverage for Innovation Technology rule would have automatically covered new FDA-approved "Breakthrough" devices for four years, under Medicare.
The policy had previously been put on hold and then proposed for cancellation. The Biden administration promises two stakeholder workshops in CY2022 on other ways to improve Medicare coverage.
A few weeks ago I posted a cloud zip file of some of the most interesting public comments in favor of MCIT (here). I also flagged a blog that was pro-MCIT by Joe Grogan, who was one of the leaders for health policy in the White House in 2019/2020. Scott Gottlieb and Grogan discussed reasons why MCIT was good in a recent webinar here.
CMS PRESS RELEASE
FINAL DECISION (FEDERAL REGISTER)
November 15, 2021. 86 FR 62944-58. Here.
There's an odd flip flop in today's final rule.